Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease.

Dawwas MF, Davies SE, Griffiths WJ, Lomas DA, Alexander GJ.

Am J Respir Crit Care Med. 2013 Mar 1;187(5):502-8. doi: 10.1164/rccm.201204-0739OC. Epub 2012 Dec 21.

PMID:
23262512
3.

Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.

Liu XD, Wu JL, Liang J, Zhang T, Sheng QS.

World J Gastroenterol. 2012 Jun 14;18(22):2784-92. doi: 10.3748/wjg.v18.i22.2784.

4.

The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.

Piitulainen E, Tanash HA.

COPD. 2015 May;12 Suppl 1:36-41. doi: 10.3109/15412555.2015.1021909.

PMID:
25938290
5.

Prognostic marker for liver disease due to alpha1-antitrypsin deficiency.

Pferdmenges DC, Baumann U, Müller-Heine A, Framke T, Pfister ED.

Klin Padiatr. 2013 Sep;225(5):257-62. doi: 10.1055/s-0033-1347196. Epub 2013 Aug 23.

PMID:
23975848
6.

The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.

Tanash HA, Nystedt-Düzakin M, Montero LC, Sveger T, Piitulainen E.

Ann Am Thorac Soc. 2015 Jun;12(6):807-12. doi: 10.1513/AnnalsATS.201410-452OC.

PMID:
25803183
7.

The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.

Bernspång E, Carlson J, Piitulainen E.

Scand J Gastroenterol. 2009;44(11):1349-55. doi: 10.3109/00365520903296669.

PMID:
19891586
8.

Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency.

Bowlus CL, Willner I, Zern MA, Reuben A, Chen P, Holladay B, Xie L, Woolson RF, Strange C.

Clin Gastroenterol Hepatol. 2005 Apr;3(4):390-6.

PMID:
15822045
9.

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

Green CE, Vayalapra S, Hampson JA, Mukherjee D, Stockley RA, Turner AM.

Thorax. 2015 Oct;70(10):939-45. doi: 10.1136/thoraxjnl-2015-206906. Epub 2015 Jul 3.

PMID:
26141072
10.

Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.

Bejarano G, Vergara M, Dalmau B, Puig J, Bella MR, Suárez D, Calvet X.

Rev Esp Enferm Dig. 2009 May;101(5):325-35. English, Spanish.

11.

A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings.

Obrador BD, Prades MG, Gómez MV, Domingo JP, Cueto RB, Rué M, Real J, Guiteras PM.

Eur J Gastroenterol Hepatol. 2006 Jan;18(1):57-62.

PMID:
16357620
12.

Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease.

Hinds R, Hadchouel A, Shanmugham NP, Al-Hussaini A, Chambers S, Cheeseman P, Mieli-Vergani G, Hadzić N.

J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):136-8.

PMID:
16819392
13.

Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.

Mostafavi B, Diaz S, Tanash HA, Piitulainen E.

Medicine (Baltimore). 2017 Mar;96(12):e6180. doi: 10.1097/MD.0000000000006180.

14.

Liver Involvement in Patients With PiZZ-Emphysema, Candidates for Lung Transplantation.

Morer L, Choudat L, Dauriat G, Durand F, Cazals-Hatem D, Thabut G, Brugière O, Castier Y, Mal H.

Am J Transplant. 2017 May;17(5):1389-1395. doi: 10.1111/ajt.14152. Epub 2017 Jan 24.

PMID:
27931086
15.

Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.

de Serres FJ, Blanco I, Fernández-Bustillo E.

COPD. 2006 Aug;3(3):133-9. Erratum in: COPD. 2006 Dec;3(4):245.

PMID:
17240615
16.

[Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis].

Park SY, Kang KH, Park JH, Lee JH, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH.

Korean J Gastroenterol. 2004 Apr;43(4):246-51. Korean.

18.

Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.

Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA.

Am J Respir Crit Care Med. 2007 Dec 15;176(12):1215-21. Epub 2007 Sep 13.

PMID:
17872489
19.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Strange C, Senior RM, Sciurba F, O'Neal S, Morris A, Wisniewski SR, Bowler R, Hochheiser HS, Becich MJ, Zhang Y, Leader JK, Methé BA, Kaminski N, Sandhaus RA; GRADS Alpha-1 Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1551-60. doi: 10.1513/AnnalsATS.201503-143OC.

20.

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Molloy K, Hersh CP, Morris VB, Carroll TP, O'Connor CA, Lasky-Su JA, Greene CM, O'Neill SJ, Silverman EK, McElvaney NG.

Am J Respir Crit Care Med. 2014 Feb 15;189(4):419-27. doi: 10.1164/rccm.201311-1984OC.

PMID:
24428606

Supplemental Content

Support Center